Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Su-Leng Tan Lee

Su-Leng Tan Lee is recorded as Board Member and CEO at BioNexus Gene Lab Corp (BGLC). BioNexus Gene Lab Corp reported in an 8-K filed November 8, 2024 that Su-Leng Tan Lee was appointed President, effective November 5, 2024. BioNexus Gene Lab Corp reported in an 8-K filed April 1, 2024 that Su-Leng Tan Lee was appointed director, effective December 11, 2023. BioNexus Gene Lab Corp reported in an 8-K filed April 1, 2024 that Su-Leng Tan Lee was appointed Chief Executive Officer and Secretary, effective December 11, 2023.

“Additionally, the Board has re-appointed Mr. Su-Leng Tan Lee as Secretary of the Company and has appointed him as President, effective immediately.”
BioNexus Gene Lab Corp Form 8-K, filed November 8, 2024 · Read the filing
“On December 11, 2023, the Board appointed (i) Mr. Chee Keong Yap as an independent director, and Mr. Su-Leng Tan Lee as director with each to serve until his successor is duly elected and qualified, or until the earlier of his death, resignation or removal,”
BioNexus Gene Lab Corp Form 8-K, filed April 1, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at BioNexus Gene Lab Corp

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.